000 | 01307 a2200361 4500 | ||
---|---|---|---|
005 | 20250514003430.0 | ||
264 | 0 | _c20020412 | |
008 | 200204s 0 0 eng d | ||
022 | _a1528-2511 | ||
024 | 7 |
_a10.1002/0470846534.ch10 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKapikian, A Z | |
245 | 0 | 0 |
_aA rotavirus vaccine for prevention of severe diarrhoea of infants and young children: development, utilization and withdrawal. _h[electronic resource] |
260 |
_bNovartis Foundation symposium _c2001 |
||
300 |
_a153-71; discussion 171-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aContraindications |
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 |
_aDiarrhea _ximmunology |
650 | 0 | 4 | _aEthics, Clinical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aLicensure |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aRotavirus Infections _ximmunology |
650 | 0 | 4 |
_aRotavirus Vaccines _xadministration & dosage |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVaccination _xadverse effects |
650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
773 | 0 |
_tNovartis Foundation symposium _gvol. 238 _gp. 153-71; discussion 171-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/0470846534.ch10 _zAvailable from publisher's website |
999 |
_c11372831 _d11372831 |